ceftriaxone NDC 25021-106 · J-Code J0696

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-106Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0106Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-106-10	25021010610	25 VIAL in 1 CARTON (25021-106-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIALMarketed from Nov 5, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ceftriaxone
Generic name (nonproprietary): ceftriaxone
Active ingredients: Ceftriaxone sodium — 1 g/1
Dosage form: Injection, Powder, For solution
Route: Intramuscular, Intravenous
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065329
Marketing start: Nov 5, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 25021-106_71bf5ebd-afe1-4906-86ef-76d7e205ec68SPL ID 71bf5ebd-afe1-4906-86ef-76d7e205ec68SPL set ID 5cf93bc5-9e4c-4734-bc02-c7d0ac071022RxCUI 1665005, 1665021, 1665046UNII 023Z5BR09K
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0696 — Injection, ceftriaxone sodium, per 250 mg

Billing unit: 250 mg. Units on the claim = dose given ÷ 250 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021010610 followed by a unit qualifier and the quantity

Package 25021-0106-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 8, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Before instituting treatment with Ceftriaxone for Injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ceftriaxone for Injection, USP and other antibacterial drugs, Ceftriaxone for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065329

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065329
Product	Strength	Form · route	Labeler	Product NDC
Ceftriaxone	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Proficient Rx LP	71205-593
Ceftriaxone	Ceftriaxone sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-346
Ceftriaxone	Ceftriaxone sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-701
Ceftriaxone	Ceftriaxone sodium 500 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-700
Ceftriaxone	Ceftriaxone sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-701
Ceftriaxone	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-702
Ceftriaxone	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	WG Critical Care, LLC	44567-702
ceftriaxone	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Sagent Pharmaceuticals	25021-107